NCT06699238

Brief Summary

This study aimed to examine whether aerobic exercises, in addition to home exercises, have anti-inflammatory effects, which are evaluated by disease activity, acute phase reactants, and cytokine levels in axial spondyloarthropathy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

November 19, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
Last Updated

November 21, 2024

Status Verified

November 1, 2024

Enrollment Period

1.6 years

First QC Date

November 19, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

axial spondyloarthritisaerobic exercisescytokinesacute phase biomarkersnon pharmacological intervention

Outcome Measures

Primary Outcomes (5)

  • ASDAS-CRP

    The Ankylosing Spondylitis Disease Activity Score (ASDAS) is an index to assess disease activity in Ankylosing Spondylitis (AS). The prefered score uses CRP. ASDAS-CRP = 0.12 x Back Pain + 0.06 x Duration of Morning Stiffness + 0.11 x Patient Global + 0.07 x Peripheral Pain/Swelling + 0.58 x Ln(CRP+1) Back pain, patient global assessment, duration of morning stiffness and peripheral pain/swelling are all assessed on a numerical rating scale (from 0 to 10). The 3 cut-offs selected to separate these states were: \<1.3 between "inactive disease" and "moderate disease activity", \<2.1 between "moderate disease activity" and "high disease activity", and \>3.5 between "high disease activity" and "very high disease activity". Cut-offs for improvement scores were: a change ≥1.1 units for "clinically important improvement"

    12 weeks

  • Tumor necrosis factor-alpha (TNF-α)

    TNF-α is a chemical messenger produced by the immune system that induces inflammation. Its relation with axial spondyloarthropathy's disease activity is uncertain but inhibition of TNF-α is one of the targets of current therapies. There were no cut-off measures for TNF-α on axial spondyloarthropathy patients.

    12 weeks

  • Interleukin-17 (IL-17)

    IL-17 is a pro-inflammatory cystine knot cytokines. They are produced by a group of T helper cell known as T helper 17 cell in response to their stimulation with IL-23. Its relation with axial spondyloarthropathy's disease activity is uncertain but inhibition of IL-17 is one of the targets of current therapies. There were no cut-off measures for IL-17 on axial spondyloarthropathy patients.

    12 weeks

  • C-reactive protein (CRP)

    CRP is an annular (ring-shaped) pentameric protein found in blood plasma, whose circulating concentrations rise in response to inflammation. It is an acute-phase protein of hepatic origin that increases following interleukin-6 secretion by macrophages and T cells. On axial spondyloarthropathy patients it may be elevated but in some patients there could be no elevation of CRP. Also it is necessary for ASDAS-CRP calculation.

    12 weeks

  • Erythrocyte Sedimentation Rate (ESR)

    Erythrocyte Sedimentation Rate (ESR) is the rate at which red blood cells in anticoagulated whole blood descend in a standardized tube over a period of one hour. On axial spondyloarthropathy patients it may be elevated but in some patients there could be no elevation of ESR. Also it is necessary for disease activity calculation (ASDAS-ESR).

    12 weeks

Secondary Outcomes (7)

  • Pain Visual Analogue Scale (VAS)

    12 weeks

  • The Bath Ankylosing Spondylitis Functional Index (BASFI)

    12 weeks

  • Bath Ankylosing Spondylitis Metrology Index (BASMI)

    12 weeks

  • Chest expansion measurement

    12 weeks

  • 6 minute walk test (6 MWT)

    12 weeks

  • +2 more secondary outcomes

Study Arms (2)

Home Exercise Group

ACTIVE COMPARATOR

The home exercise group performed only standard conventional exercises for 12 weeks, 3 days a week, once a day for 30 min, including cervical, thoracic, and lumbar spine flexibility, shoulder muscles, hip flexors, hamstring and quadriceps muscle stretching, spinal flexor stretching, and extensor strengthening and breathing exercises program was shown by the same physician. Patient compliance with the exercise program was monitored weekly using telemedicine.

Other: Home Exercise

Aerobic Exercise Group

EXPERIMENTAL

The aerobic exercise group performed the following training: warm-up for 5 min, walking for 20 min at an intensity that would use 60-70% of the HR reserve, and cool down for 5 min. Additionally, they performed standard conventional exercises at home for 12 weeks, 3 days a week, once a day for 30 min, including cervical, thoracic, and lumbar spine flexibility, shoulder muscles, hip flexors, hamstring and quadriceps muscle stretching, spinal flexor stretching, and extensor strengthening and breathing exercises program was shown by the same physician. The aerobic exercise group performed on a treadmill under the supervision of a physician.

Other: Home ExerciseOther: Aerobic exercise

Interventions

Standard conventional exercise for 12 weeks, 3 days a week, once a day for 30 min, including cervical, thoracic, and lumbar spine flexibility, shoulder muscles, hip flexors, hamstring and quadriceps muscle stretching, spinal flexor stretching, and extensor strengthening and breathing exercises program was shown by the same physician. Patient compliance with the exercise program was monitored weekly using telemedicine.

Also known as: Conventional Exercise
Aerobic Exercise GroupHome Exercise Group

The aerobic exercise group performed the following training: warm-up for 5 min, walking for 20 min at an intensity that would use 60-70% of the HR reserve, and cool down for 5 min. Additionally, they performed standard conventional exercises at home for 12 weeks, 3 days a week, once a day for 30 min, including cervical, thoracic, and lumbar spine flexibility, shoulder muscles, hip flexors, hamstring and quadriceps muscle stretching, spinal flexor stretching, and extensor strengthening and breathing exercises program was shown by the same physician. Patient compliance with the exercise program was monitored weekly using telemedicine.The aerobic exercise group performed on a treadmill under the supervision of a physician.

Aerobic Exercise Group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • AxSpA diagnosis according to the ASAS classification criteria
  • Voluntary participation in the study
  • Age 20-65 ages
  • Regular use of disease-modifying anti-rheumatic drugs at a stable dosage for at least 3 months
  • Regular use of NSAID at a stable dosage for at least 4 weeks
  • Presence of low disease activity (1.3 ≤ ASDAS-CRP\< 2.1)
  • Having a phone number that can be used to communicate with oneself or a family member
  • At least a primary school graduate.

You may not qualify if:

  • Presence of active peripheral joint involvement
  • Having used a biological agent at any time before
  • Exercising regularly for the previous 6 months
  • The presence of cardiovascular, orthopedic, and neurological problems that may prevent exercise (unstable angina, uncontrolled sinus tachycardia, presence of severe aortic stenosis, uncontrolled atrial or ventricular arrhythmia, 3rd degree atrioventricular block, fracture, prosthesis, neuropathy, myopathy)
  • Any other respiratory or neuromuscular disease that affects the respiratory muscles
  • Presence of malignancy
  • Presence of pregnancy
  • Having undergone any surgery in the previous 6 months,
  • Presence of severe psychiatric illness
  • Findings related to infection during interrogation
  • Having an infection in the last 3 months
  • Communication problems
  • Having known diabetes mellitus
  • The presence of severe comorbidity that may affect the kidneys and livers
  • Inability to participate in at least 75% of the exercises
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital Physical Medicine and Rehabilitation Hospital

Ankara, 06170, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Axial Spondyloarthritis

Interventions

Exercise

Condition Hierarchy (Ancestors)

SpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritis

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ajda Bal, MD, Professor

    Ankara Etlik City Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups, one group was provided home exercise program and one group run on the treadmill in addition to their home exercise program
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

November 19, 2024

First Posted

November 21, 2024

Study Start

November 1, 2021

Primary Completion

May 31, 2023

Study Completion

July 21, 2023

Last Updated

November 21, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations